• Corpus ID: 201992586

Tumor Lysis Syndrome Associated with Prostate Cancer: An Under-recognized Oncologic Emergency

  title={Tumor Lysis Syndrome Associated with Prostate Cancer: An Under-recognized Oncologic Emergency},
  author={Jue Wang},
  • Jue Wang
  • Published 20 September 2018
  • Medicine
Background: Prostate cancer is the second cause of cancer related deaths in men, despite a decrease in incidence and mortality rates in the United States. Tumor lysis syndrome (TLS) is an oncologic emergency with few treatment options. While TLS has been extensively documented in patients with hematological malignancies, it is rarely described in patients with prostate cancer. The objective of this study was to investigate the clinical characteristics and outcomes of TLS, a rare but life… 

Tables from this paper

Clinical Features, Treatment, and Outcome of Tumor Lysis Syndrome in Germ Cell Tumors

  • Jue Wang
  • Medicine
    Journal of Urology & Nephrology Studies
  • 2019
Considering the life-threatening nature of TLS in GCTs, health professionals should be alert and monitor for TLS in order to prevent or treat this potentially fatal complication.

Intricate Interplay of Entwined Metabolic and Inflammatory Life-threatening Processes in Tumor Lysis Syndrome Complicating Prostate Cancer: A Systematic Review with a Single Institution Experience

Doctors should consider TLS as a differential diagnosis when evaluating AKI and electrolyte abnormalities, particularly in patients with metastatic PRCA and high disease burden, even before the initiation of cytotoxic therapy.



Spontaneous tumor lysis syndrome in a patient with metastatic prostate cancer.

The case is reported of a 56-year-old African-American man who presented with a recent diagnosis of prostate cancer, abdominal pain, elevated transaminases, renal insufficiency, hyperkalemia, and hyperuricemia, consistent with spontaneous TLS in the setting of metastatic prostate cancer.

Spontaneous tumor lysis syndrome in a giant neglected breast cancer.

A new case of STLS is presented in a 37-year-old female with giant neglected metastatic breast cancer who subsequently developed acute oliguric renal failure and multiple electrolyte abnormalities requiring hemodialysis and died eight days after admission.

Tumor lysis syndrome during radiotherapy for prostate cancer with bone and bone marrow metastases without visceral metastasis

A 60-year-old male patient with metastatic prostate cancer, who showed improvement in overall status and had no requirement for hemodialysis up to this time, developed sudden impairment in Overall status, dyspnea, and hypotension on the 11th day of follow-up and died.

Successful prevention of tumor lysis syndrome using recombinant urate oxidase in patient with metastasic and bulky prostate rhabdomyosarcoma

An adolescent case of metastatic rhabdomyosarcoma, in which clinical TLS was successfully prevented using rUO, is reported, and it is recommended that RMS should be treated like neuroblastoma because it grows rapidly and is highly chemosensitive.

Treatment-naïve spontaneous tumor lysis syndrome in metastatic prostate adenocarcinoma: An unusual suspect.

Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer

  • S. Sorscher
  • Medicine
    Cancer Chemotherapy and Pharmacology
  • 2004
What appears to be to the first reported case of TLS associated with chemotherapeutic treatment of metastatic prostate cancer after treatment of nonhematologic malignancies reported between 1977 and 2002 is described.

Tumor lysis syndrome in anti-androgen-treated metastatic prostate cancer

Tests showed that urinary alkalinization can further decrease ionized calcium and cause calcium–phosphate salts to precipitate in renal tubules worsening renal function, which needs to be remembered as a possible adverse event that is increasingly associated with solid tumors.

Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer

A case of TLS is reported in a patient with metastatic adenocarcinoma of the prostate after treatment with paclitaxel chemotherapy.

SPONTANEOUS TUMOR LYSIS SYNDROME: A case report and review of literature

Clinicians should keep in mind the possibility of STLS in patients with solid tumor and should have the experience to interpret the clinical and laboratory tests to identify it and rapidly initiate its management.

Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade.

A patient who suffered from this complication and hepatic encephalopathy after combined androgen blockade (CAB) is reported on, which is believed to be the first report of its kind in the world.